SIGLEC7, which belongs to the sialic acid-binding immunoglobulin-like lectins (SIGLECS) family predominantly expressed in leukocytes, has been previously identified as a potential immune checkpoint in bladder cancer [42]. The gene discussed is SIGLEC7; the disease is urinary bladder cancer.